Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster its antimicrobial resistance (AMR) expertise.
8 months ago

Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ) is possibly approaching a major achievement in its business, so we would...
4 days ago

Novo Holdings and Gurnet Point have added antibiotics maker Paratek Pharma to their fold in a biopharma M&A deal worth approximately $462...
11 months ago

Gurnet Point Capital and Novo Holdings Acquires Paratek Pharmaceuticals ... Gurnet Point Capital and Novo Holdings A/S completed the acquisition...
7 months ago

Paratek Pharmaceuticals Inc. ex-investors are challenging its $462 million sale to Novo Holdings A/S and Gurnet Point Capital LLC,...
3 months ago

Gurnet Point and Novo Holdings complete take-private buyout of Paratek Pharmaceuticals. The purchase price is about $462 million. ... Gurnet Point...
8 months ago

Firm represents healthcare fund that invests in de-risked life sciences companies in US$462 million take private transaction.
11 months ago

CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital (“Gurnet Point”) and Novo Holdings A/S (“Novo Holdings”) announced...
8 months ago

Activist investor NexPoint threatens to block Paratek's $462M sale ... Paratek Pharmaceuticals' annual meeting is set for July 6, but fireworks...
10 months ago

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) to Gurnet...
11 months ago